Arthur A Hancock

Two Novel and Selective Nonimidazole Histamine H3 Receptor Antagonists A-304121 and A-317920: I. In Vitro Pharmacological Effects

Michael Williams, Youssef L Bennani, M. Williams, 2003, Journal of Pharmacology and Experimental Therapeutics.

In vitro SAR of pyrrolidine-containing histamine H3 receptor antagonists: trends across multiple chemical series.

T. Vortherms, A. Hancock, Marlon D Cowart, 2008, Bioorganic & medicinal chemistry letters.

Synthesis and SAR of aminoalkoxy-biaryl-4-carboxamides: novel and selective histamine H3 receptor antagonists.

Youssef L Bennani, G. Fox, A. Hancock, 2003, Bioorganic & medicinal chemistry letters.

Effect of fiduxosin, an antagonist selective for alpha(1A)- and alpha(1D)-adrenoceptors, on intraurethral and arterial pressure responses in conscious dogs.

Michael Williams, David G Witte, Arthur A Hancock, 2002, The Journal of pharmacology and experimental therapeutics.

4-[6-(2-Aminoethyl)naphthalen-2-yl]benzonitriles are potent histamine H3 receptor antagonists with high CNS penetration.

Youssef L Bennani, A. Hancock, K. Marsh, 2007, Bioorganic & medicinal chemistry letters.

Pharmacological Properties and Procognitive Effects of ABT-288, a Potent and Selective Histamine H3 Receptor Antagonist

Min Zhang, Min Zhang, K. Browman, 2012, Journal of Pharmacology and Experimental Therapeutics.

Synthesis and SAR of 5-amino- and 5-(aminomethyl)benzofuran histamine H3 receptor antagonists with improved potency.

Jill M. Wetter, A. Hancock, K. Marsh, 2005, Journal of medicinal chemistry.